Pulmonary hypertension among maintenance hemodialysis patients in Somalia: a hospital-based observational study

Springer Science and Business Media LLC - Tập 74 - Trang 1-7 - 2022
Gökhan Alıcı1, Mohamud Mire Waberi1, Mohamed Abdullahi Mohamud1, Ahmed Muhammad Bashir1, Ömer Genç2
1Department of Cardiology, Turkey Recep Tayyip Erdogan, Somalia Mogadishu Training and Research Hospital, Mogadishu, Somalia
2Department of Cardiology, Agri Training and Research Hospital, Agri, Turkey

Tóm tắt

This study aims to examine the prevalence and related factors of pulmonary hypertension (PHT) in patients on hemodialysis (HD) at the only referral institution in Somalia. A total of one hundred and forty-three patients  who had received regular HD therapy for at least three months and underwent transthoracic echocardiography (TTE) were included in the study. Patients with a systolic pulmonary artery pressure (sPAP) value > 35 mmHg at rest on TTE were considered having PHT. The relationship of TTE parameters, demographic, and clinic characteristics of participants with PHT were evaluated. The number of patients with PHT was 73 (51%). The mean age was 54.2 ± 18.4 years. The majority of patients were 65 years of age or older. (n: 46, 32.2%) and 65 (45.5%) were male. Median sPAP was found to be 35 mmHg. Systolic pulmonary artery pressure was positively correlated with right atrium (RA) diameter (r: 0.6, p < 0.001) and negatively correlated with left ventricular ejection fraction (LVEF) (r: − 0.4, p < 0.001). In addition, LVEF, RA diameter, presence of pericardial effusion (PE) were found to be independent predictors of PHT. Pulmonary hypertension has a relatively high prevalence in end-stage renal disease (ESRD) patients on regular HD. Besides, the presence of PE and certain right and left heart parameters were independently associated with PHT.

Tài liệu tham khảo

Maron BA, Brittain EL, Choudhary G, Gladwin MT (2018) Redefining pulmonary hypertension. Lancet Respir Med 6(3):168–170 Simonneau G, Montani D, Celermajer DS et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 53(1):1801913 Al-Qadi M, LeVarge B, Ford HJ (2020) Epidemiology, pathogenesis, and clinical approach in Group 5 pulmonary hypertension. Front Med (Lausanne) 7:616720 O’Leary JM, Assad TR, Xu M et al (2017) Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulm Circ 7(3):674–683 Han BG, Kim J, Jung IY, Son JW (2019) Relationship between volume status and possibility of pulmonary hypertension in dialysis naive CKD5 patients. PLOS ONE. 14(9):e0221970 Yoo HHB, Dos Reis R, Telini WM et al (2017) Association of pulmonary hypertension with inflammation and fluid overload in hemodialysis patients. Iran J Kidney Dis 11(4):303–308 Genctoy G, Arikan S, Eldem O (2015) Pulmonary hypertension associates with malnutrition and body composition hemodialysis patients. Ren Fail 37(2):273–279 Mitchell C, Rahko PS, Blauwet LA et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 32(1):1–64 Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S (2018) Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis. Am J Kidney Dis 72(1):75–83 Bolignano D, Pisano A, Coppolino G, Tripepi GL, D’Arrigo G (2019) Pulmonary hypertension predicts adverse outcomes in renal patients: a systematic review and meta-analysis. Ther Apher Dial 23(4):369–384 Fadaii A, Koohi-Kamali H, Bagheri B, Hamidimanii F, Taherkhanchi B (2013) Prevalence of pulmonary hypertension in patients undergoing hemodialysis. Iran J Kidney Dis 7(1):60–63 Hayati F, Beladi Mousavi SS, Mousavi Movahed SM, Mofrad BM (2017) Pulmonary hypertension among patients undergoing hemodialysis. J Renal Inj Prev 6(2):122–126 Mousavi SA, Mahdavi-Mazdeh M, Yahyazadeh H et al (2008) Pulmonary hypertension and predisposing factors in patients receiving hemodialysis. Iran J Kidney Dis 2(1):29–33 Alıcı G, Genç Ö (2021) Spectrum of cardiovascular diseases at a referral tertiary care hospital in Somalia, Mogadishu: an echocardiographic study. BMC Cardiovasc Disord 21(1):599 Alıcı G, Genç Ö (2021) Prevalence and etiologies of pulmonary hypertension at Somalia-Turkey Training and Research Hospital in Mogadishu. Pan Afr Med J 40:215 Reque J, Garcia-Prieto A, Linares T et al (2017) Pulmonary hypertension is associated with mortality and cardiovascular events in chronic kidney disease patients. Am J Nephrol 45(2):107–114 Hansrivijit P, Chen YJ, Lnu K et al (2021) Prediction of mortality among patients with chronic kidney disease: a systematic review. World J Nephrol 10(4):59–75 Reque J, Quiroga B, Ruiz C et al (2016) Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in haemodialysis patients. Nephrology (Carlton) 21(4):321–326 Navaneethan SD, Roy J, Tao K et al (2016) Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 27(3):877–886 Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG (2008) Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 86(10):1384–1388 Barberà JA, Román A, Gómez-Sánchez M et al (2018) Guidelines on the diagnosis and treatment of pulmonary hypertension: summary of recommendations. Arch Bronconeumol (Engl Ed) 54(4):205–215 Zhang Y, Ding XH, Rao R, et al. The Prevalence of Pulmonary Hypertension Among Maintenance Dialysis Patients With ESRD and Its Associated Factors: A Retrospective Study. Front Med (Lausanne). 2020;7:570874. Sato T, Tsujino I, Oyama-Manabe N et al (2013) Right atrial volume and phasic function in pulmonary hypertension. Int J Cardiol 168(1):420–426 Tudoran M, Ciocarlie T, Mates A, Pescariu SA, AbuAwwad A, Tudoran C (2020) Pulmonary hypertension in patients with end stage renal disease undergoing hemodialysis. Niger J Clin Pract 23(2):198–204 Rehman KA, Betancor J, Xu B et al (2017) Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology. Clin Cardiol 40(10):839–846 Alpert MA, Ravenscraft MD (2003) Pericardial involvement in end-stage renal disease. Am J Med Sci 325(4):228–236 Batal O, Dardari Z, Costabile C, Gorcsan J, Arena VC, Mathier MA (2015) Prognostic value of pericardial effusion on serial echocardiograms in pulmonary arterial hypertension. Echocardiography 32(10):1471–1476 Raymond RJ, Hinderliter AL, Willis PW et al (2002) Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 39(7):1214–1219